| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918638 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
Prostate SABR VMAT is optimal using 1PA. 6Â mm CTV-PTV margins, compatible with daily fiducial-based IGRT, are consistently feasible in terms of target objectives and OAR constraints.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Louise J. Murray, Vivian Cosgrove, John Lilley, Jonathan Sykes, Christopher M. Thompson, Kevin Franks, David Sebag-Montefiore, Ann M. Henry,